<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04165863</url>
  </required_header>
  <id_info>
    <org_study_id>Fibrin4Fast</org_study_id>
    <nct_id>NCT04165863</nct_id>
  </id_info>
  <brief_title>Effectiveness of Treatment With Rich Platelet Fibrin (PRF) VS Gold Standard in Patients Undergoing Knee Replacement</brief_title>
  <acronym>Fibrin4Fast</acronym>
  <official_title>Effectiveness of Treatment With Rich Platelet Fibrin (PRF) VS Gold Standard in the Healing Process of Surgical Wounds in Patients Undergoing Knee Replacement</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Istituto Ortopedico Rizzoli</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Istituto Ortopedico Rizzoli</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Randomized controlled single blind trial for the evaluation of the treatment of the surgical
      wound healing process with Platelet-Rich-Fibrin compared to the gold standard (without
      Platelet-Rich-Fibrin) in patients undergoing knee replacement.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">November 30, 2019</start_date>
  <completion_date type="Anticipated">October 30, 2020</completion_date>
  <primary_completion_date type="Anticipated">October 30, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>clinical improvement of the healing process</measure>
    <time_frame>2 weeks</time_frame>
    <description>Clinical improvement of the healing process, assessed by application of the Hollander Wound Evaluation Scales at 2 weeks of follow up</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Dermatology life quality</measure>
    <time_frame>3 days, 15 days and 1 month</time_frame>
    <description>Dermatology life quality index improvement at 3 days, 15 days and 1 month</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">104</enrollment>
  <condition>Knee Disease</condition>
  <arm_group>
    <arm_group_label>A</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>treatment of the surgical wound healing process with Platelet-rich-fibrin in patients undergoing total knee replacement surgery</description>
  </arm_group>
  <arm_group>
    <arm_group_label>B</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Gold standard treatment of the surgical wound healing process without Platelet-rich-fibrin in patients undergoing total knee replacement surgery</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>total knee replacement surgery</intervention_name>
    <description>total knee replacement surgery</description>
    <arm_group_label>A</arm_group_label>
    <arm_group_label>B</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Males or females undergoing a total knee prosthesis.

          -  Willingness and ability to comply with the study procedures and visit schedules and
             ability to follow verbal and written instructions.

          -  Hb &gt; 11 g/dl; Platelet value &gt; 150.000 plt/mmc;

          -  Patients with non clinical alteration of ECG;

          -  Signature of informed consent;

        Exclusion Criteria:

          -  Patients incapable of understanding and of wanting;

          -  Systemic disorders such as diabetes, rheumatic diseases;

          -  Patients with malignancy;

          -  Thyroid metabolic disorders ;

          -  Abuse of alcohol, drugs and pharmaceutical drugs

          -  Body mass index &gt; 40;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Stefano Zaffagnini, MD</last_name>
    <phone>051.63.66</phone>
    <phone_ext>520</phone_ext>
    <email>stefano.zaffagnini@ior.it</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Alessandro Di Martino, MD</last_name>
    <phone>051.63.66</phone>
    <phone_ext>567</phone_ext>
    <email>alessandro.dimartino@ior.it</email>
  </overall_contact_backup>
  <results_reference>
    <citation>Harato K, Tanikawa H, Morishige Y, Kaneda K, Niki Y. What are the important surgical factors affecting the wound healing after primary total knee arthroplasty? J Orthop Surg Res. 2016 Jan 13;11:7. doi: 10.1186/s13018-016-0340-y.</citation>
    <PMID>26762213</PMID>
  </results_reference>
  <results_reference>
    <citation>Galat DD, McGovern SC, Larson DR, Harrington JR, Hanssen AD, Clarke HD. Surgical treatment of early wound complications following primary total knee arthroplasty. J Bone Joint Surg Am. 2009 Jan;91(1):48-54. doi: 10.2106/JBJS.G.01371.</citation>
    <PMID>19122078</PMID>
  </results_reference>
  <results_reference>
    <citation>Rui M, Zheng X, Sun SS, Li CY, Zhang XC, Guo KJ, Zhao FC, Pang Y. A prospective randomised comparison of 2 skin closure techniques in primary total hip arthroplasty surgery. Hip Int. 2018 Jan;28(1):101-105. doi: 10.5301/hipint.5000534.</citation>
    <PMID>29148019</PMID>
  </results_reference>
  <verification_date>November 2019</verification_date>
  <study_first_submitted>November 14, 2019</study_first_submitted>
  <study_first_submitted_qc>November 14, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">November 18, 2019</study_first_posted>
  <last_update_submitted>November 14, 2019</last_update_submitted>
  <last_update_submitted_qc>November 14, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">November 18, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

